Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wüster C. Bengtsson BA, et al. Among authors: bennmarker h. J Clin Endocrinol Metab. 1999 Nov;84(11):3929-35. doi: 10.1210/jcem.84.11.6088. J Clin Endocrinol Metab. 1999. PMID: 10566630
Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stâhl E, Thorén M, Westberg B, Wilton P, Wüster C. Monson JP, et al. Among authors: bennmarker h. Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9. doi: 10.1046/j.1365-2265.2000.01104.x. Clin Endocrinol (Oxf). 2000. PMID: 10971444
Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster C; KIMS International Study Board of KIMS Study Group. Feldt-Rasmussen U, et al. Among authors: bennmarker h. Eur J Endocrinol. 2002 Jan;146(1):67-74. doi: 10.1530/eje.0.1460067. Eur J Endocrinol. 2002. PMID: 11751070
The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.
Wüster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P; KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database. Wüster C, et al. Among authors: bennmarker h. J Bone Miner Res. 2001 Feb;16(2):398-405. doi: 10.1359/jbmr.2001.16.2.398. J Bone Miner Res. 2001. PMID: 11204440 Free article.
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401.
Bergh J, Wiklund T, Erikstein B, Fornander T, Bengtsson NO, Malmström P, Kellokumpu-Lehtinen P, Anker G, Bennmarker H, Wilking N. Bergh J, et al. Among authors: bennmarker h. Ann Oncol. 1998 Apr;9(4):403-11. doi: 10.1023/a:1008252014312. Ann Oncol. 1998. PMID: 9636831 Free article. Clinical Trial.